• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Women's Health

FDA approves 4-year intrauterine device

August 7, 2017 By Sarah Faulkner

Allergan, Medicines360

Allergan (NYSE:AGN) and women’s health nonprofit Medicines360 said today that the FDA approved a supplemental new drug application to extend the duration of use for Liletta, a levonorgestrel-releasing intrauterine device, for up to four years. The hormone-releasing device was first approved in February 2015 and it won additional approval in January last year for a single-handed […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Wall Street Beat, Women's Health Tagged With: Allergan, Medicines360

Study: Vaginal ring for HIV prevention safe in adolescent girls

July 25, 2017 By Sarah Faulkner

A monthly vaginal ring that releases anti-HIV drugs was found to be safe and acceptable in an NIH-funded study of adolescent girls, according to data presented today at the 9th IAS Conference on HIV Science in Paris. The experimental ring boasted better adherence throughout the study compared to a daily oral tablet, the researchers reported. […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Women's Health Tagged With: National Institutes of Health

Study: Antiretroviral drug-eluting ring safe in breastfeeding mothers

July 24, 2017 By Sarah Faulkner

Baby

An antiretroviral drug released from an experimental vaginal ring to protect women against HIV is absorbed in low concentrations into breastmilk, according to researchers from the NIH-funded Microbicide Trials Network. The team touted data today from a Phase I trial of the device at the 9th IAS Conference on HIV Sciences in Paris. The dapivirine […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Women's Health Tagged With: National Institutes of Health

Inovio prices $75m public offering

July 20, 2017 By Sarah Faulkner

Inovio Pharmaceuticals

Inovio Pharmaceuticals (NSDQ:INO) said today that it priced its underwritten public offering of 12.5 million shares of common stock at $6.00 apiece. The offering is expected to bring in nearly $75 million for the Plymouth Meeting, Penn.-based company. The offering, which is expected to close on July 25, includes a 30-day option for underwriters to buy […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Funding Roundup, Immunotherapy, Oncology, Wall Street Beat, Women's Health Tagged With: Inovio Pharmaceuticals

Inovio looks to raise $75m in public offering

July 19, 2017 By Sarah Faulkner

Inovio Pharmaceuticals

Inovio Pharmaceuticals (NSDQ:INO) said yesterday that it is launching an underwritten public offering to sell $75 million shares of common stock. The Plymouth Meeting, Penn.-based company said it plans to grant underwriters an option to buy up to $11.3 million additional shares of common stock. Inovio is slated to use its newly-acquired funds to support general […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Immunotherapy, Oncology, Wall Street Beat, Women's Health Tagged With: Inovio Pharmaceuticals

CDC chief propped up controversial anti-aging medicine in private practice

July 17, 2017 By Sarah Faulkner

CDC

Before the newly-appointed CDC head Dr. Brenda Fitzgerald ran the public health department for the state of Georgia, she was a board-certified OB/GYN with a private practice. But according to a report from Forbes, she not only provided women’s healthcare in the 30 years she practiced medicine – she was also a fellow in “anti-aging medicine.” […]

Filed Under: Featured, Hospital Care, Pharmaceuticals, Policy, Women's Health Tagged With: Centers for Disease Control & Prevention

Inovio launches late-stage cervical dysplasia trial after FDA lifts hold

June 8, 2017 By Sarah Faulkner

Inovio Pharmaceuticals

Shares in Inovio Pharmaceuticals (NSDQ:INO) jumped more than 10% after it announced that it is launching a Phase III clinical study of its investigational DNA immunotherapy candidate designed to treat cervical dysplasia caused by human papillomavirus. The moves comes after the FDA lifted a hold that it placed on the clinical program in October last year. At […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Immunotherapy, Oncology, Women's Health Tagged With: Inovio Pharmaceuticals

Kentucky doc gets jail time for bad opioid prescription habits & Medicaid fraud

June 7, 2017 By Sarah Faulkner

Prescription drugs

Dr. George Kudmani, an OB/GYN from Kentucky, was sentenced to 4 years in prison this week after a federal jury ruled that he was guilty of inappropriately doling out opioids and Medcaid fraud. The jury found Kudmani guilty of 19 counts of unlawful distribution of controlled substances and 8 counts of health care fraud. After Kudmani serves his […]

Filed Under: Featured, Hospital Care, Legal News, Pharmaceuticals, Women's Health Tagged With: Centers for Medicare and Medicaid Services (CMS)

Novavax touts nanoparticle RSV vaccine in women of child-bearing age

June 7, 2017 By Sarah Faulkner

Novavax

Novavax Inc. (NSDQ:NVAX) touted data today from the second Phase II trial of its RSV F nanoparticle vaccine candidate in women of child-bearing age. The research was published in the journal Vaccine. Novavax’s nanomedicine vaccine is being developed to protect infants from the respiratory syncytial virus. The Gaithersburg, Md.-based company presented top-line data from the Phase […]

Filed Under: Clinical Trials, Featured, Nanoparticles, Wall Street Beat, Women's Health Tagged With: novavax

Infertility: There could be a 3D printing solution

May 16, 2017 By Chris Newmarker

New Northwestern University research offers a potential 3D printing solution for women’s infertility – providing hope for cancer survivors who want to start families. The Northwestern researchers successfully 3D printed a bioprosthetic mouse ovary that ovulated when implanted inside a live mouse. Mice with the bioprosthetic ovaries were able to give birth to live pups, […]

Filed Under: Featured, Hydrogels, Implants, Regenerative Medicine, Women's Health Tagged With: 3D printing, bioprinting, infertility, Northwestern University

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS